The latest biotech news

News and Trends 25 Mar 2025

AbbVie and Genmab: Can a legal battle break a billion-dollar bond?

As AbbVie accuses Genmab of unlawfully using proprietary ADC technology, find out about their collaboration and the dispute opposing them.

March 25, 2025 - 5 minutesmins - By Jules Adam

News and Trends 24 Mar 2025

First-ever RIPTAC enters clinic: all you need to know about this new cancer approach

The first RIPTAC has just hit the clinic. Learn about this new technology that is being developed by Halda Therapeutics.

March 24, 2025 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 21 Mar 2025

Depression drug trials are failing—and placebos are to blame

In this article, we examine recent clinical trial failures and discuss potential pathways forward for antidepressant drug research.

March 21, 2025 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 10 Mar 2025

23andMe: the collapse of a genomics giant

23andMe was once worth $6 billion and is now a penny stock. Layoffs, data breaches, and mass resignations plagued the genomics giant. How did it all unfold?

March 10, 2025 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 6 Mar 2025

Top biotech deals of February 2025

Find out about the top biotech partnership deal of February 2025. Small molecules, T-cell engagers, and RNA medicines, were all part of major collaborations.

March 6, 2025 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 24 Feb 2025

Over $3 billion in a month: Why is Eli Lilly starting 2025 on a buying spree?

This year has seen Eli Lilly sign several licensing deals to bolster its position across a range of therapeutic areas amid growing drug revenues.

February 24, 2025 - 7 minutesmins - By Roohi Mariam Peter

News and Trends 19 Feb 2025

Trade war: how new U.S. tariffs will impact the biopharma industry

The U.S. plans to impose trade tariffs on imports. How does this affect the biopharma industry?

February 19, 2025 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 13 Feb 2025

DeepMind AlphaFold’s alumnus raises $40m for Latent Labs, a new AI biotech startup

Find out about a new AI-driven company that emerges from stealth today to create novel protein – Latent Labs.

February 13, 2025 - 6 minutesmins - By Jules Adam

News and Trends 6 Feb 2025

Top biotech deals of January 2025

January 2025 kicked off in full swing with several biotech deals in the biopharma industry.

February 6, 2025 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 4 Feb 2025

Akribion Therapeutics emerges from stealth with programmable cell depletion RNA technology

Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach

February 4, 2025 - 6 minutesmins - By Jules Adam

News and Trends 31 Jan 2025

U.K. biotech defies the odds, raising £3.5B in 2024

The U.K. biotech sector raised £3.5 billion in equity financing last year amid challenges, according to a BIA report.

January 31, 2025 - 7 minutesmins - By Roohi Mariam Peter

News and Trends 28 Jan 2025

ITM-11 succeeds in phase 3: The first big win for radiopharma?

Discover ITM and its cancer candidate ITM-11, as it brings one of the first big wins the radiopharmaceutical sector awaits.

January 28, 2025 - 9 minutesmins - By Jules Adam

Resources

Categories

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

AbbVie and Genmab: Can a legal battle break a billion-dollar bond?

First-ever RIPTAC enters clinic: all you need to know about this new cancer approach

Depression drug trials are failing—and placebos are to blame

23andMe: the collapse of a genomics giant

Top biotech deals of February 2025

Over $3 billion in a month: Why is Eli Lilly starting 2025 on a buying spree?

Trade war: how new U.S. tariffs will impact the biopharma industry

DeepMind AlphaFold’s alumnus raises $40m for Latent Labs, a new AI biotech startup

Top biotech deals of January 2025

Akribion Therapeutics emerges from stealth with programmable cell depletion RNA technology

U.K. biotech defies the odds, raising £3.5B in 2024

ITM-11 succeeds in phase 3: The first big win for radiopharma?

Subscribe to our newsletter to get the latest biotech news!

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!